Literature DB >> 22289105

Non healing leg ulcer infected with Stenotrophomonas maltophilia: first reported case from India.

Falguni Nag1, Abhishek De, Kokila Banerjee, Gobinda Chatterjee.   

Abstract

Stenotrophomonas maltophilia is a recently described organism which was mainly reported either in nosocomial setup, or in immunosuppresed individuals. This was rarely reported as cutaneous pathogenic organism causing cellulitis-like lesion, paronychia, mucocutaneous ulcers and ecthyma gangrenosum in immunocompromised individuals. Here we describe a case of leg ulcer caused by S. maltophilia in an immuno-competent patient. The infection was possibly community acquired as the patient had no exposure to hospital environment. The bacillus was sensitive to cotrimoxazole and levofloxacin, and the patient was successfully treated with cotrimoxazole. Our case is unique not only because it is probably the first ever case of leg ulcer caused by S. maltophilia, but also because of its unusual occurrence in immunocompetent patient.
© 2012 The Authors. International Wound Journal © 2012 John Wiley & Sons Ltd and Medicalhelplines.com Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22289105      PMCID: PMC7950645          DOI: 10.1111/j.1742-481X.2012.00938.x

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  7 in total

1.  Pseudomonas maltophilia infection in an abattoir worker.

Authors:  P H Dyte; J A Gillians
Journal:  Med J Aust       Date:  1977-03-26       Impact factor: 7.738

2.  Ecthyma Gangrenosum: A Rare Cutaneous Manifestation Caused by Stenotrophomonas maltophilia in a Leukemic Patient.

Authors:  Young Min Son; So Young Na; Hye Young Lee; Jin Ok Baek; Jong Rok Lee; Joo Young Roh
Journal:  Ann Dermatol       Date:  2009-11-30       Impact factor: 1.444

3.  Skin manifestation of Stenotrophomonas maltophilia infection--a case report and review article.

Authors:  Wan Yee Teo; Mei Yoke Chan; Ching Mei Lam; Chia Yin Chong
Journal:  Ann Acad Med Singap       Date:  2006-12       Impact factor: 2.473

Review 4.  Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Authors:  M Denton; K G Kerr
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Mucocutaneous and soft tissue infections caused by Xanthomonas maltophilia. A new spectrum.

Authors:  S E Vartivarian; K A Papadakis; J A Palacios; J T Manning; E J Anaissie
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

6.  Nosocomial and community-acquired Xanthomonas maltophilia infection in tropical Australia.

Authors:  T Heath; B Currie
Journal:  J Hosp Infect       Date:  1995-08       Impact factor: 3.926

7.  Novel nosocomial infections by Stenotrophomonas maltophilia: first reported case from Lucknow, North India.

Authors:  Chiranjoy Mukhopadhyay; Anudita Bhargava; Archana Ayyagari
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

  7 in total
  4 in total

Review 1.  Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccines.

Authors:  Jean-Louis Excler; Julie Ake; Merlin L Robb; Jerome H Kim; Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2014-06-11

2.  Clinico-Etiological Evaluation of Chronic Leg Ulcer in a Tertiary Care Center of Eastern India.

Authors:  Falguni Nag; Gobinda Chatterjee; Arghyaprasun Ghosh; Abhishek De
Journal:  Indian J Dermatol       Date:  2020 Nov-Dec       Impact factor: 1.494

3.  Alterations in skin microbiome mediated by radiotherapy and their potential roles in the prognosis of radiotherapy-induced dermatitis: a pilot study.

Authors:  Mohammed Ramadan; Helal F Hetta; Moustafa M Saleh; Mohamed E Ali; Ali Aya Ahmed; Mohammed Salah
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

4.  Stenotrophomonas maltophilia periprosthetic joint infection after reverse total shoulder arthroplasty.

Authors:  Michael E Hantes; Fotios Papageorgiou; George A Komnos
Journal:  IDCases       Date:  2020-05-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.